Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi Mizuno

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Metabolism and Pharmacokinetics|December 25, 2004
Drug transporters: their role and importance in the selection and development of new drugsNaomi Mizuno, Yuichi Sugiyama
Nanomaterials (Basel, Switzerland)|April 8, 2020
In Situ Study of the Impact of Aberration-Corrected Electron-Beam Lithography on the Electronic Transport of Suspended Graphene DevicesNaomi Mizuno, Fernando Camino, Xu Du
Nature Communications|November 15, 2013
Ballistic-like supercurrent in suspended graphene Josephson weak linksNaomi Mizuno, Bent Nielsen, Xu Du
Autoimmunity Reviews|December 13, 2021
The influence of cytokines on the complex pathology of ulcerative colitisHiroshi Nakase, Noriko Sato, Naomi Mizuno, et al.
Pharmacological Reviews|July 19, 2003
Impact of drug transporter studies on drug discovery and developmentNaomi Mizuno, Takuro Niwa, Yoshihisa Yotsumoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2007
Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugateNaomi Mizuno, Tsuyoshi Takahashi, Yumiko Iwase, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2007
Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one)Naomi Mizuno, Tsuyoshi Takahashi, Hiroyuki Kusuhara, et al.
Intestinal Research|October 14, 2024
Patient preferences for advanced therapies in ulcerative colitis using conjoint analysisTaku Kobayashi, Naomi Mizuno, Noriko Sato, et al.
Nature Communications|November 24, 2025
Localizing individual exciton on a quantum Hall antidotRui Pu, Naomi Mizuno, Fernando Camino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout miceNaomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Pharmacokinetics|December 25, 2004
Drug transporters: their role and importance in the selection and development of new drugsNaomi Mizuno, Yuichi Sugiyama
Nanomaterials (Basel, Switzerland)|April 8, 2020
In Situ Study of the Impact of Aberration-Corrected Electron-Beam Lithography on the Electronic Transport of Suspended Graphene DevicesNaomi Mizuno, Fernando Camino, Xu Du
Nature Communications|November 15, 2013
Ballistic-like supercurrent in suspended graphene Josephson weak linksNaomi Mizuno, Bent Nielsen, Xu Du
Autoimmunity Reviews|December 13, 2021
The influence of cytokines on the complex pathology of ulcerative colitisHiroshi Nakase, Noriko Sato, Naomi Mizuno, et al.
Pharmacological Reviews|July 19, 2003
Impact of drug transporter studies on drug discovery and developmentNaomi Mizuno, Takuro Niwa, Yoshihisa Yotsumoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2007
Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugateNaomi Mizuno, Tsuyoshi Takahashi, Yumiko Iwase, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2007
Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one)Naomi Mizuno, Tsuyoshi Takahashi, Hiroyuki Kusuhara, et al.
Intestinal Research|October 14, 2024
Patient preferences for advanced therapies in ulcerative colitis using conjoint analysisTaku Kobayashi, Naomi Mizuno, Noriko Sato, et al.
Nature Communications|November 24, 2025
Localizing individual exciton on a quantum Hall antidotRui Pu, Naomi Mizuno, Fernando Camino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout miceNaomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, et al.
Pageof 2